F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 110,510 shares at $25.94 ($2.8M) on 2023-01-12, disclosed to the SEC on 2023-01-13.
Open-market sale of $2.8M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.32 | 9,719 | $236K | 8.5% |
| 2 | $24.32 | 9,719 | $236K | 8.5% |
| 3 | $25.13 | 23,695 | $595K | 21.3% |
| 4 | $25.13 | 23,695 | $595K | 21.3% |
| 5 | $25.94 | 21,841 | $567K | 20.3% |
| 6 | $25.94 | 21,841 |
| $567K |
| 20.3% |
| Total | $25.31 avg | 110,510 | $2.8M | 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |